Onyia Jude
Insider CIK 1894425 · VYGR Director · NBIX Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-09-11 | 2026-09-15 | 1,936 | $156.22 | $302.4K | 22,647 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-09-11 | 2026-09-15 | 3,587 | — | $0 | 24,583 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-09-11 | 2026-09-15 | 1,936 | $156.22 | $302.4K | 22,647 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-09-11 | 2026-09-15 | 3,587 | — | $0 | 24,583 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2026-08-04 | 2026-08-05 | 2,409 | — | $0 | 20,996 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2026-08-04 | 2026-08-05 | 2,409 | — | $0 | 20,996 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2026-06-05 | 2026-06-09 | 2,441 | — | $0 | 23,405 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-06-01 | 2026-06-02 | 11,000 | — | $0 | 13,268 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-06-01 | 2026-06-02 | 11,000 | $160.25 | $1.76M | 25,846 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-06-01 | 2026-06-02 | 11,000 | $84.74 | $932.1K | 36,846 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-05-27 | 2026-05-29 | 11,000 | — | $0 | 24,268 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-05-27 | 2026-05-29 | 11,000 | $84.74 | $932.1K | 36,846 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-05-27 | 2026-05-29 | 11,000 | $155.53 | $1.71M | 25,846 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2026-02-20 | 2026-02-23 | 3,110 | — | $0 | 25,670 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-13 | 2026-02-17 | 2,690 | — | $0 | 5,380 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-02-13 | 2026-02-17 | 55,119 | — | $0 | 55,119 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-13 | 2026-02-17 | 2,717 | — | $0 | 2,717 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-02-13 | 2026-02-17 | 9,669 | — | $0 | 9,669 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 1,452 | $124.12 | $180.2K | 18,349 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-13 | 2026-02-17 | 2,717 | — | $0 | 21,066 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 1,466 | $124.12 | $182.0K | 19,600 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-02-13 | 2026-02-17 | 19,935 | — | $0 | 39,535 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 10,755 | $124.12 | $1.33M | 28,780 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-13 | 2026-02-17 | 2,690 | — | $0 | 19,801 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-12 | 2026-02-17 | 2,560 | — | $0 | 7,681 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-12 | 2026-02-17 | 1,426 | $123.10 | $175.5K | 17,111 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-12 | 2026-02-17 | 2,560 | — | $0 | 18,537 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-01-31 | 2026-02-03 | 238 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-01-31 | 2026-02-03 | 238 | — | $0 | 16,119 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-01-31 | 2026-02-03 | 142 | $136.06 | $19.3K | 15,977 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-11-29 | 2025-12-02 | 4,426 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-11-29 | 2025-12-02 | 4,426 | — | $0 | 18,129 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2025-11-29 | 2025-12-02 | 2,248 | $152.16 | $342.1K | 15,881 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2025-09-03 | 2025-09-04 | 1,470 | — | $0 | 13,703 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2025-08-05 | 2025-08-07 | 3,116 | — | $0 | 15,173 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-07-09 | 2025-07-11 | 59,819 | — | $0 | 35,268 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-07-09 | 2025-07-11 | 59,819 | $84.74 | $5.07M | 78,108 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-07-09 | 2025-07-11 | 59,819 | $130.46 | $7.80M | 18,289 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-07-02 | 2025-07-07 | 20,362 | — | $0 | 95,087 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-07-02 | 2025-07-07 | 20,362 | $130.13 | $2.65M | 18,289 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-07-02 | 2025-07-07 | 20,362 | $84.74 | $1.73M | 38,651 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2025-06-03 | 2025-06-04 | 24,000 | — | $0 | 24,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 2,690 | — | $0 | 8,070 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 2,717 | — | $0 | 5,434 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 1,432 | $116.83 | $167.3K | 16,846 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 2,690 | — | $0 | 19,536 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 1,447 | $116.75 | $168.9K | 18,089 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 2,717 | — | $0 | 18,278 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 54,645 | — | $0 | 54,645 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 10,241 | — | $0 | 10,241 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-01-31 | 2025-02-04 | 238 | — | $0 | 238 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-01-31 | 2025-02-04 | 238 | — | $0 | 15,687 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-01-31 | 2025-02-04 | 126 | $152.97 | $19.3K | 15,561 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-11-29 | 2024-12-03 | 4,426 | — | $0 | 4,426 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-11-29 | 2024-12-03 | 4,426 | — | $0 | 17,780 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-11-29 | 2024-12-03 | 2,331 | $126.29 | $294.4K | 15,449 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 24,000 | — | $0 | 24,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 54,069 | — | $0 | 54,069 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 10,760 | — | $0 | 10,760 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-13 | 2024-02-15 | 1,432 | $132.94 | $190.4K | 13,128 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-01-31 | 2024-02-02 | 126 | $141.94 | $17.9K | 11,843 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-11-29 | 2023-12-01 | 2,331 | $113.57 | $264.7K | 11,732 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-08-21 | 2023-08-23 | 3,198 | $107.37 | $343.4K | 9,638 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-07 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 44,000 | — | $0 | 44,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 67,541 | — | $0 | 67,541 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 10,868 | — | $0 | 10,868 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 4,508 | $102.30 | $461.2K | 6,525 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-01-31 | 2023-02-02 | 126 | $108.48 | $13.7K | 2,477 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-11-29 | 2022-12-01 | 2,331 | $121.90 | $284.1K | 2,366 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-01-31 | 2022-02-02 | 6,464 | — | $0 | 6,464 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-01-31 | 2022-02-02 | 950 | — | $0 | 950 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-11-29 | 2021-12-01 | 120,169 | — | $0 | 120,169 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-11-29 | 2021-12-01 | 17,702 | — | $0 | 17,702 | SEC↗ |